Company intelligence / Profile preview

Gregand Innovations

Ownership: Private
Development stage: Commercial

Overview

Gregand Innovations SAS is developing and clinically evaluating the Caloprothese Connected Kit (CCK), a medical device comprising a sleeve and sock designed to address rebellious neuropathic pain and phantom limb pain in amputees. The company's main program is currently recruiting participants for clinical evaluation. No published results or commercialized products are reported as of March 2025. [1]

Therapeutic areas: Neurology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Gregand Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gregand Innovations.

Explore the full profile